PCRX Live signals | Maximize Profits with Getagraph.com

BUY 105130 min ago

@ $29.13

Issued: 13 Feb 2024 @ 14:52

Return: -9.62%

Previous signal: Feb 13 - 10:58

Previous signal: Sell

Return: -1.81 %

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 16:00):

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States...

Stats
Today's Volume	287 074
Average Volume	504 704
Market Cap	1.22B
EPS	$0 ( 2024-02-29 )
Next earnings date	( $0.650 ) 2024-05-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	29.58
ATR14	$0.0190 (0.07%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-06	Pace Gary W	Sell	1 066	Common Stock
2024-03-07	Pace Gary W	Sell	28 257	Common Stock
2024-03-08	Pace Gary W	Sell	90 000	Common Stock
2024-02-05	Williams Kristen	Buy	33 700	Common Stock
2024-02-05	Gaugler Daryl	Buy	33 700	Common Stock

INSIDER POWER
58.64
Last 95 transactions
Buy: 1 581 500 \| Sell: 429 616

Volume Correlation

Long: 0.26 (neutral)

Short: -0.39 (neutral)

Signal:(56.993) Neutral

Pacira Biosciences Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pacira Biosciences Inc Correlation - Currency/Commodity

0.25
( neutral )

0.42
( neutral )

0.00
( neutral )

-0.25
( neutral )

-0.33
( neutral )

-0.28
( neutral )

Pacira Biosciences Inc Financials

Annual	2023
Revenue:	$674.98M
Gross Profit:	$433.02M (64.15 %)
EPS:	$0.910

FY	2023
Revenue:	$674.98M
Gross Profit:	$433.02M (64.15 %)
EPS:	$0.910

FY	2022
Revenue:	$666.82M
Gross Profit:	$467.53M (70.11 %)
EPS:	$0.350

FY	2021
Revenue:	$541.53M
Gross Profit:	$401.28M (74.10 %)
EPS:	$0.944

Financial Reports:

No articles found.

Pacira Biosciences Inc

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Realtime updates for Pacira Biosciences Inc [PCRX]

Upcoming Earnings Alert